4
Changes in Ownership
Moleculin Biotech, Inc. Filed Acc 0001437749-26-021610
Chief Financial Officer gave up 72 shares (to pay taxes)
- Chief Financial Officer acquired 283 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Foster Jonathan P. · Chief Financial Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-06-20 | Exercise or conversion : show line 1 in the form | +109 | 12,238 | D | ||
| 2026-06-20 | Shares withheld for taxes : show line 2 in the form | −31 | $2.88 | $89 | 12,207 | D |
| 2026-06-22 | Exercise or conversion : show line 3 in the form | +174 | 12,381 | D | ||
| 2026-06-22 | Shares withheld for taxes : show line 4 in the form | −41 | $3.12 | $128 | 12,340 | D |
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-06-20 | Exercise or conversion : show line 5 in the form Restricted Stock Units | −109 | 147,892 | D |
| 2026-06-22 | Exercise or conversion : show line 6 in the form Restricted Stock Units | −174 | 147,718 | D |
Loading xslF345X06/rdgdoc.xml…